Skip to main content
SpringerLink
Log in

Current Concepts in the Treatment of Disorders of Micturition

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Disorders of micturition may be divided into disturbances of the storage function of the bladder, and disturbances of the emptying function. The main symptoms of disturbances of storage function are frequency, urgency and incontinence. Hyperactivity of the bladder may lead to urge incontinence, and incompetence of the urethral closure mechanism to stress incontinence.

There are many drugs available for treating bladder hyperactivity, but their efficacy as judged from controlled clinical trials (when available) is often limited. Bladder contraction in man is mediated by stimulation of muscarinic receptors, and when given parenterally anticholinergic drugs have been shown to depress bladder hyperactivity irrespective of the underlying cause. Clinically, however, treatment of urge incontinence with anticholinergic drugs is often unsatisfactory. Lack of effect of oral treatment and systemic side effects limit the use of available agents. Drugs with ‘mixed’ actions (anticholinergic and ‘direct’ muscle effects), for example oxybutynin and terodiline, have well-documented efficacy in bladder hyperactivity. Side effects are common with oxybutynin; terodiline seems to be well tolerated.

The aim of drug treatment of stress incontinence is to increase outflow resistance. Although there is only limited possibility of improving the condition with drugs, beneficial effects can be obtained in some patients by use of orally active α-adrenoceptor agonists (e.g. phenylpropanolamine) and/or oestrogens.

The main symptom of disturbed bladder emptying is urinary retention. Drug therapy is aimed at improving the contractile activity of the detrusor or reducing urethral outflow resistance. Drugs used for improving bladder contractility include parasympathomimetic agents, e.g. bethanechol or carbachol, and intravesical instillation of prostaglandins. Although the efficacy of both types of treatment is open to question, bethanechol seems to be widely used.

Increased outflow resistance may be seen in patients with parasympathetic decentralisation of the lower urinary tract or in patients with benign prostatic hypertrophy. These patients may respond favourably to α-adrenoceptor blockers such as phenoxybenzamine or prazosin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abrams PH, Dunn M. A double-blind trial of bromocriptine in the treatment of idiopathic detrusor instability. British Journal of Urology 51: 24–27, 1979

    PubMed  CAS  Google Scholar 

  • Aladjem M, Wohl R, Boichis H, Orda S, Lotan D, et al. Desmopressin in nocturnal enuresis. Archives of Diseases of Childhood 57: 137–140, 1982

    CAS  Google Scholar 

  • Åmark P, Nergård A, Kinn AC. The effect of noradrenaline on the contractile response of the urinary bladder. Scandinavian Journal of Urology and Nephrology 20: 203–207, 1986

    PubMed  Google Scholar 

  • Anderson GF, Fredericks CM. Characterization of the oxybutynin antagonism of drug-induced spasms in detrusor. Pharmacology 15: 31–39, 1977

    PubMed  CAS  Google Scholar 

  • Anderson RS, Murray K. The effect of the calcium antagonist flunarizine on the detrusor — a combined clinical and pharmacological study. Proceedings of the International Continence Society, 14th Annual Meeting, pp. 301–302, Innsbruck, 1984

  • Andersson K-E. Clinical pharmacology of terodiline. Scandinavian Journal of Urology and Nephrology 87: 13–20, 1984

    PubMed  CAS  Google Scholar 

  • Andersson K-E. Clinical relevance of some findings in neuroanatomy and neurophysiology of the lower urinary tract. Clinical Science 70(Suppl. 14): 21–32, 1986

    Google Scholar 

  • Andersson K-E, Bengtsson B, Paulsen O. Desamino-8-D-arginine vasopressin (DDAVP): pharmacology and clinical use. Drugs of Today, in press, 1988

    Google Scholar 

  • Andersson K-E, Ek A, Hedlund H, Mattiasson A. Effects of prazosin on isolated human urethra and in patients with lower motor neuron lesions. Investigative Urology 19: 39–42, 1981

    PubMed  CAS  Google Scholar 

  • Andersson K-E, Forman A. Effects of prostaglandins on the smooth muscle of the urinary tract. Acta Pharmacologica et Toxicologica 43(Suppl. II): 90–95, 1978

    PubMed  CAS  Google Scholar 

  • Andersson K-E, Forman A. Effects of calcium channel blockers on urinary tract smooth muscle. Acta Pharmacologica et Toxicologica 58(Suppl. II): 193–200, 1986

    PubMed  CAS  Google Scholar 

  • Andersson K-E, Fovaeus M, Morgan ED, McLorie G. Comparative effects of five calcium channel blockers on the atropine resistant contraction in electrically stimulated rabbit urinary bladder. Neurourology and Urodynamics 5: 579–586, 1987a

    Google Scholar 

  • Andersson K-E, Hedlund H, Larsson B, Mattiasson A, Sjögren C. Ketanserin interaction with urethral alpha-adrenoceptors. Journal of Urology 137: 534–538, 1987b

    PubMed  CAS  Google Scholar 

  • Andersson K-E, Sjögren C. Aspects on the physiology and pharmacology of the bladder and urethra. Progress in Neurobiology 19: 71–89, 1982

    PubMed  CAS  Google Scholar 

  • Awad SA, Bruce G, Carrocampi JW, Lin M, Marks GS. Distribution of α- and β-adrenoceptor in human urinary bladder. British Journal of Pharmacology 50: 525–529, 1974

    PubMed  CAS  Google Scholar 

  • Awad SA, Bryniak S, Downie JW, Bruce AW. The treatment of the uninhibited bladder with dicyclomine. Journal of Urology 117: 161–163, 1977

    PubMed  CAS  Google Scholar 

  • Awad SA, Downie JW, Kiriluta HG. Alpha-adrenergic agents in urinary disorders of the proximale urethra, part I: sphincteric incontinence. British Journal of Urology 50: 332–335, 1978

    PubMed  CAS  Google Scholar 

  • Bagger PV, Fischer-Rasmussen W, Hansen R. Emepronium carrageenate: clinical effects and urinary excretion in treatment of female urge incontinence. Scandinavian Journal of Urology and Nephrology 19: 31–35, 1985

    PubMed  CAS  Google Scholar 

  • Baldessarini KJ. Drugs in the treatment of psychiatric disorders. In Gilman et al. (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 387–445, McMillan Publishing Co., 1985

    Google Scholar 

  • Bates P, Bradley WE, Glen E, Melchior H, Rowan D, et al. First report on the standardisation of terminology of lower urinary tract function. British Journal of Urology 48: 39–42, 1976

    Google Scholar 

  • Beck RP, Arnausch T, King C. Results in treating 210 patients with detrusor over-activity incontinence of urine. American Journal of Obstetrics and Gynecology 125: 593–596, 1976

    PubMed  CAS  Google Scholar 

  • Beisland HO, Fossberg E. The effects of terodiline and meladrazine on severe motor urge incontinence in geriatric patients. Journal of American Geriatric Society 33: 29–32, 1985

    CAS  Google Scholar 

  • Beisland HO, Fossberg E, Sander S. On incompetent urethral closure mechanism: treatment with estriol and phenylpropanolamine. Scandinavian Journal of Urology and Nephrology 60 (Suppl.): 67–69, 1981

    Google Scholar 

  • Benson GS, Sarshite SA, Raezer DM, Wein AJ. Bladder muscle contractility: comparative effects and mechanisms of action of atropine, propantheline, flavoxate, and imipramine. Urology 9: 31–35, 1977

    PubMed  CAS  Google Scholar 

  • Birkasova M, Birkas O, Flynn MJ, Cort JH. Desmopressin in the management of nocturnal enuresis in children: a double blind study. Pediatrics 62: 970–974, 1978

    PubMed  CAS  Google Scholar 

  • Blaivas JG. If you currently prescribe bethanechol chloride for urinary retention, please raise your hand. Neurourology and Urodynamics 3: 209–210, 1984

    Google Scholar 

  • Blaivas JG, Labib KB, Michalik J, Zayed AAH. Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications. Journal of Urology 124: 259–262, 1980

    PubMed  CAS  Google Scholar 

  • Boman J, von Garrelts B. Emepronium bromide (Cetiprin®): its effect on bladder pressure and urinary flow in healthy subjects. Scandinavian Journal of Urology and Nephrology 7: 153–157, 1973

    PubMed  CAS  Google Scholar 

  • Bonnesen T, Tikjøb G, Kamper AL, Bay Nielsen AM, Thorup Andersen J, et al. Effect of emepronium bromide (Cetiprin) on symptoms and urinary bladder function after transurethral resection of the prostate. Urologia Internationalis 39: 318–320, 1984

    PubMed  CAS  Google Scholar 

  • Bradley DV, Cazort RJ. Relief of bladder spasms by flavoxate: a comparative study. Journal of Clinical Pharmacology 10: 65–68, 1970

    CAS  Google Scholar 

  • Briggs KS, Castleden CM, Asher MJ. The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly. Journal of Urology 123: 665–666, 1980

    PubMed  CAS  Google Scholar 

  • Brooks ME, Braf ZF. Oxybutynin chloride (Ditropan) — clinical uses and limitations. Paraplegia 18: 64–68, 1980

    PubMed  CAS  Google Scholar 

  • Bultitude MI, Hills NH, Shuttleworth KED. Clinical and experimental studies on the action of prostaglandins and their synthesis on detrusor muscle in vitro and in vivo. British Journal of Urology 48: 631–637, 1976

    PubMed  CAS  Google Scholar 

  • Caine M. The place of pharmacologic treatment in benign prostatic hyperplasia. Seminars in Urology 3: 311–316, 1985

    PubMed  CAS  Google Scholar 

  • Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. Journal of Urology 136: 1–4, 1986

    PubMed  CAS  Google Scholar 

  • Cardozo LD, Cooper D, Versi E. Oxybutynin chloride in the management of idiopathic detrusor instability. Neurourology and Urodynamics 6: 256–257, 1987

    Google Scholar 

  • Cardozo LD, Stanton SL. An objective comparison of the effects of parenterally administered drug in patients suffering from detrusor instability. Journal of Urology 122: 58–59, 1979

    PubMed  CAS  Google Scholar 

  • Cardozo LD, Stanton SL. A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. Journal of Urology 123: 399–401, 1980

    PubMed  CAS  Google Scholar 

  • Cardozo LD, Stanton SL, Robinson H, Hole D. Evaluation on flurbiprofen in detrusor instability. British Medical Journal 280: 281–282, 1980

    PubMed  CAS  Google Scholar 

  • Castleden CM, George CF, Renwick AG, Asher MJ. Imipramine — a possible alternative to current therapy for urinary incontinence in the elderly. Journal of Urology 125: 318–320, 1981

    PubMed  CAS  Google Scholar 

  • Castleden CM, Morgan B. The effect of β-adrenoceptor agonists on urinary incontinence in the elderly. British Journal of Clinical Pharmacology 10: 619–620, 1980

    PubMed  CAS  Google Scholar 

  • Cazzulani P, Panzarasa R, De Stefani C, Graziani G. Mechanism of flavoxate antispasmodic activity comparative in vitro studies. Archives Internationales de Pharmacodynamie et de Thérapie 274: 189–200, 1985

    PubMed  CAS  Google Scholar 

  • Cazzulani P, Panzarasa R, Luca C, Oliva D, Graziani G. Pharmacological studies on the mode of action of flavoxate. Archives Internationales de Pharmacodynamie et de Thérapie 268: 301–312, 1984

    PubMed  CAS  Google Scholar 

  • Delaere KPJ, Debruyne FM. The effects of serotonin antagonist on the lower urinary tract. Proceedings of the International Continence Society 12th Annual Meeting, Leiden, 1982

  • Delaere KPJ, Debruyne FMJ, Booij LHDJ. Influence of ketanserin (serotonin antagonist) on bladder and urethral function. Urology 29: 669–673, 1987

    PubMed  CAS  Google Scholar 

  • Delaere KPJ, Debruyne FMJ, Moonen WA. Has bromocriptine a place in the treatment of the unstable bladder? British Journal of Urology 50: 169–171, 1978

    PubMed  CAS  Google Scholar 

  • Delaere KPJ, Michiels HGE, Debruyne FMJ, Moonen WA. Flavoxate hydrochloride in the treatment of detrusor instability. Urologia Internationalis 32: 377–381, 1977

    PubMed  CAS  Google Scholar 

  • Delaere KPJ, Strijbos WEM. Desmopressin in the management of nocturnal enuresis in young adults. Neurourology and Urodynamics 6: 262–263, 1987

    Google Scholar 

  • Delaere KPJ, Thomas CMG, Moonen WA, Debruyne FMJ. The value of intravesical prostaglandin E2 and F2α in women with abnormalities of bladder emptying. British Journal of Urology 53: 306–309, 1981

    PubMed  CAS  Google Scholar 

  • Desmond AD, Bultitude MI, Hills NH, Shuttleworth KED. Clinical experience with intravesical prostaglandin E2: a post-operative study of 36 patients. British Journal of Urology 32: 357–366, 1980

    Google Scholar 

  • Dhattiwala AS. The effect of imipramine on isolated innervated guinea-pig and rat urinary bladder preparations. Journal of Pharmacy and Pharmacology 28: 453–454, 1976

    PubMed  CAS  Google Scholar 

  • Diokno AC, Hyndman CW, Hardy DA, Lapides J. Comparison of action of imipramine (Tofranil) and propantheline (Probanthine) on detrusor contraction. Journal of Urology 107: 42–43, 1972

    PubMed  CAS  Google Scholar 

  • Diokno AC, Lapides J. Oxybutynin: a new drug with analgesic and anticholinergic properties. Journal of Urology 108: 307–309, 1972

    PubMed  CAS  Google Scholar 

  • Diokno AC, Taub M. Ephedrine in treatment of urinary incontinence. Urology 5: 624–625, 1975

    PubMed  CAS  Google Scholar 

  • Donker PJ, Van der Sluis C. Action of β-adrenergic blocking drugs on the urethral pressure profile. Urologia Internationalis 31: 6–12, 1976

    PubMed  CAS  Google Scholar 

  • Downie JW. Bethanechol chloride in urology — a discussion of issues. Neurourology and Urodynamics 3: 211–222, 1984

    CAS  Google Scholar 

  • Downie JW, Karmazyn M. Mechanical trauma to bladder epithelium liberates prostanoids which modulate neurotransmission in rabbit detrusor muscle. Journal of Pharmacology and Experimental Therapeutics 230: 445–449, 1984

    PubMed  CAS  Google Scholar 

  • Downie JW, Moochala SM, Bialik GJ. The role of reflexes in modifying the response to bethanechol chloride: a basis for selectivity of action on the bladder. Neurourology and Urodynamics 2: 301–309, 1983

    CAS  Google Scholar 

  • Downie JW, Twiddy DAS, Awad SA. Antimuscarinic and noncompetitive antagonist properties of dicyclomine hydrochloride in isolated human and rabbit bladder muscle. Journal of Pharmacology and Experimental Therapeutics 201: 662–668, 1977

    PubMed  CAS  Google Scholar 

  • Ek A, Andersson K-E, Gullberg B, Ulmsten K. The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile. Scandinavian Journal of Urology and Nephrology 12: 105–110, 1978a

    PubMed  CAS  Google Scholar 

  • Ek A, Andersson K-E, Ulmsten U. The effects of norephedrine and bethanechol on the human urethral closure pressure profile. Scandinavian Journal of Urology and Nephrology 12: 97–104, 1978b

    PubMed  CAS  Google Scholar 

  • Ekman G, Andersson K-E, Rud T, Ulmsten U. A double-blind, cross-over investigation on the effects of terodiline in women with unstable bladder. Acta Pharmacologica et Toxicologica 46(Suppl. I): 39–43, 1980

    PubMed  Google Scholar 

  • Enhörning GE. Simultaneous recording of intra-vesical and intraurethral pressure. Acta Chirurgica Scandinavica (Suppl. 76): 1–68, 1961

    Google Scholar 

  • Fanciullacci F, Sandri S, Zanollo A, Catanzaro F. The effect of flunarizine in the treatment of incontinence due to bladder instability. Proceedings of the ICS 15th Annual Meeting, pp. 352–353, London, 1985

  • Farrar DJ, Osborne JL. The use of bromocriptine in the treatment of the unstable bladder. British Journal of Urology 48: 235–238, 1976

    PubMed  CAS  Google Scholar 

  • Ferrari A, Costa M, Baresi L, Candotti G. Flunarizine, calcium antagonist, versus fentonium bromide (Ulcesium), parasympatholytic and oestriol as a therapy for urinary incontinence in idiopathic bladder instability. Proceedings of the ICS 15th Annual Meeting, pp. 359–360, London, 1985

  • Finkbeiner AE. Is bethanechol chloride clinically effective in promoting bladder emptying: a literature review. Journal of Urology 134: 443–449, 1985

    PubMed  CAS  Google Scholar 

  • Fischer CP, Diokno A, Lapides J. The anticholinergic effects of dicyclomine hydrochloride for uninhibited neurogenic bladder dysfunction. Journal of Urology 120: 328–329, 1978

    PubMed  CAS  Google Scholar 

  • Fischer-Rasmussen W, Multicentre Study Group. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence: a multicentre study. Scandinavian Journal of Urology and Nephrology (Suppl. 87): 35–47, 1984

    Google Scholar 

  • Forman A, Andersson K-E, Henriksson L, Rud T, Ulmsten U. Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo. Acta Pharmacologica et Toxicologica 43: 111–118, 1978

    PubMed  CAS  Google Scholar 

  • Fredericks CM, Green RL, Anderson GF. Comparative in vitro effects of imipramine, oxybutynine and flavoxate on rabbit detrusor. Urology 12: 487–491, 1978

    PubMed  CAS  Google Scholar 

  • Gajewski JB, Awad SA. Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. Journal of Urology 135: 966–968, 1986

    PubMed  CAS  Google Scholar 

  • Gerstenberg T, Blaabjerg J, Nielsen ML, Clausen S. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia: a urodynamic investigation. Investigative Urology 18: 29–31, 1980

    PubMed  CAS  Google Scholar 

  • Gerstenberg TC, Klarskov P, Ramirez D, Hald T. Terodiline in the treatment of women with urgency and motor urge incontinence. British Journal of Urology 58: 129–133, 1986

    PubMed  CAS  Google Scholar 

  • Gilja I, Radej M, Kovacic M, Parazajdes J. Conservative treatment of female stress incontinence with imipramine. Journal of Urology 132: 909–911, 1984

    PubMed  CAS  Google Scholar 

  • Gleason DM, Reilly RJ, Bottacini MR, Pierce MJ. The urethral continence zone and its relation to stress incontinence. Journal of Urology 112: 81–88, 1974

    PubMed  CAS  Google Scholar 

  • Gosling JA, Gilpin SA, Dixon JS, Gilpin CJ. Decrease in the autonomic innervation of human detrusor. Journal of Urology 136: 501–504, 1986

    PubMed  CAS  Google Scholar 

  • Gotoh M, Hassouna M, Elhilali MM. Intravesical instillation of verapamil and its effect on detrusor contractility: in vitro and in vivo studies. Journal of Urology 135: 218a, 1986

    Google Scholar 

  • Grüneberger A. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. British Journal of Obstetrics and Gynaecology 91: 275–278, 1984

    PubMed  Google Scholar 

  • Hachen HJ. Clinical and urodynamic assessment of alpha adrenolytic therapy in patients with neurogenic bladder function. Paraplegia 18: 229–238, 1980

    PubMed  CAS  Google Scholar 

  • Hedlund H, Andersson K-E. Effects of prazosin and carbachol in patients with benign prostatic obstruction. Scandinavian Journal of Urology and Nephrology, in press, 1988

    Google Scholar 

  • Hedlund H, Andersson K-E, Ek A. Effects of prazosin in patients with benign prostatic obstruction. Journal of Urology 130: 275–278, 1983

    PubMed  CAS  Google Scholar 

  • Henriksson L, Andersson K-E, Ulmsten K. The urethral pressure profiles in continent and stress incontinent women. Scandinavian Journal of Urology and Nephrology 13: 5–10, 1979

    Google Scholar 

  • Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 46: 854–855, 1983

    CAS  Google Scholar 

  • Hilton P, Stanton SL. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. British Journal of Urology 54: 252–255, 1982

    PubMed  CAS  Google Scholar 

  • Homsy YL, Nsouli I, Hamburger B, Laberge I, Schick E. Effects of oxybutynin on vesicourethral reflux in children. Journal of Urology 134: 1168–1171, 1985

    PubMed  CAS  Google Scholar 

  • Hørby-Petersen J, Schmidt PF, Meyhoff HH, Frimodt-Møler C, Mathiesen FR. The effects of a new serotonin receptor antagonist (ketanserin) on lower urinary tract function in patients with prostatism. Journal of Urology 133: 1095–1098, 1985

    Google Scholar 

  • Husted S, Andersson K-E, Sommer L, Østergaard JR. Anticholinergic and calcium antagonistic effects of terodiline in rabbit urinary bladder. Acta Pharmacologica et Toxicologica 46(Suppl. I): 20–30, 1980

    PubMed  CAS  Google Scholar 

  • Jensen Jr D. Uninhibited neurogenic bladder treated with prazosin. Scandinavian Journal of Urology and Nephrology 15: 229–233, 1981

    PubMed  Google Scholar 

  • Jeremy JY, Tsang V, Mikhailidis DP, Rogers H, Morgan RJ, et al. Eicosanoid synthesis by human urinary bladder mucosa: pathological implications. British Journal of Urology 59: 36–39, 1987

    PubMed  CAS  Google Scholar 

  • Johns A, Tasker JJ, Johnson CE, Theman MA, Paton DM. The mechanism. of action of dicyclomine hydrochloride on rabbit detrusor muscle and vas deferons. Archives Internationales de Pharmacodynamie et de Thérapie 224: 109–113, 1976

    PubMed  CAS  Google Scholar 

  • Johnsen S, Koefoed-Nielsen B, Tos M. Emepronium (Cetiprin®) and corrosive injuries in the mouth and oesophagus. Ugeskrift for Laeger 144: 1477–1479, 1982

    PubMed  CAS  Google Scholar 

  • Jonas U, Petri E, Kissel J. Effect of flavoxate on hyperactive detrusor muscle. European Journal of Urology 5: 106–109, 1979

    CAS  Google Scholar 

  • Kaisary AV. Beta-adrenoceptor blockade in the treatment of female stress urinary incontinence. Journal d’Urologie (Paris) 90: 351–353, 1984

    CAS  Google Scholar 

  • Kavin H. Oesophageal ulceration due to emepronium bromide. Lancet 1: 424–425, 1977

    PubMed  CAS  Google Scholar 

  • Khanna OP, DiGregorio GJ, Barbieri EJ, McMichael RF, Ruch E. In vitro study of antispasmodic effects of dicyclomine hydrochloride on vesicourethral smooth muscle of guinea pig and rabbit. Urology 13: 457–462, 1979

    PubMed  CAS  Google Scholar 

  • Kiesswetter H, Schober W. Lioresal in the treatment of neurogenic bladder dysfunction. Urologia Internationalis 30: 63–66, 1975

    PubMed  CAS  Google Scholar 

  • Kinder RB, Mundy AR. Atropine blockade of nerve-mediated stimulation of the human detrusor. British Journal of Urology 57: 418–421, 1985

    PubMed  CAS  Google Scholar 

  • Kobler E, Buhler H, Nuesch HJ, Deyhle P. Medikament induzierte sophagusulzera. Deutsche Medizinische Wochenschrift 103: 1035–1037, 1978

    PubMed  CAS  Google Scholar 

  • Kohler FP, Morales PA. Cystometric evaluation of flavoxate hydrochloride in normal and neurogenic bladder. Journal of Urology 100: 729–730, 1968

    PubMed  CAS  Google Scholar 

  • Krane RJ, Olsson CA. Phenoxybenzamine in neurogenic bladder dysfunction, part II: clinical considerations. Journal of Urology 104: 612–615, 1973

    Google Scholar 

  • Kunin SA, Limbert DJ, Platzker ACG, McGinley J. The efficacy of imipramine in the management of enuresis. Journal of Urology 104: 612–615, 1970

    PubMed  CAS  Google Scholar 

  • Larsen JJ. Alpha- and beta-adrenoceptors in the detrusor muscle and bladder base of the pig and beta-adrenoceptors in the detrusor muscle of man. British Journal of Pharmacology 65: 215–222, 1979

    PubMed  CAS  Google Scholar 

  • Larsson B, Andersson K-E, Batra S, Mattiasson A, Sjögren C. Effects of estradiol on norepinephrine-induced contraction, alpha-adrenoceptor number and norepinephrine content in the female rabbit urethra. Journal of Pharmacology and Experimental Therapeutics 229: 557–563, 1984

    PubMed  CAS  Google Scholar 

  • Larsson-Backström C, Arrhenius E, Sagge K. Comparison of the calcium-antagonistic effects of terodiline, nifedipine and verapamil. Acta Pharmacologica et Toxicologica 57: 8–17, 1985

    PubMed  Google Scholar 

  • Laval KU, Lutzeyer W. Spontaneous phasic activity of the detrusor: a cause of uninhibited contractions in unstable bladder. Urologia Internationalis 35: 182–187, 1980

    PubMed  CAS  Google Scholar 

  • Leslie CA, Pavlakis AJ, Wheeler JS, Siroky MB, Krane RJ. Release of arachidonate cascade products by the rabbit bladder neurophysiological significance? Journal of Urology 132: 376–379, 1984

    PubMed  CAS  Google Scholar 

  • Lindholm P, Lose G. Terbutaline (Bricanyl®) in the treatment of female urge incontinence. Urologia Internationalis 41: 158–160, 1986

    PubMed  CAS  Google Scholar 

  • Lish PM, Labudde JA, Peters EL, Robbins SI. Oxybutynin — a musculotropic antispasmodic drug with moderate anticholinergic action. Archives Internationales de Pharmacodynamie et de Thérapie 156: 467–489, 1965

    PubMed  CAS  Google Scholar 

  • Low JA. Urethral behaviour during the involuntary detrusor contraction. American Journal of Obstetrics and Gynecology 128: 32–39, 1977

    PubMed  CAS  Google Scholar 

  • Lukkarinen O, Gröhn P, Wilen-Rosenqvist G, Junsela H, Sotarauta M, et al. A controlled, double-blind, crossover study of terodiline in motor urge incontinence. Annals Chirurgiae et Gynaecologiae 76: 128–132, 1987

    CAS  Google Scholar 

  • MacFarlane JR, Tolley DA. The effect of terodiline on patients with detrusor instability. Scandinavian Journal of Urology and Nephrology (Suppl. 87): 51–54, 1984

    Google Scholar 

  • Månsson W, Sundin T, Gullberg B. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. Scandinavian Journal of Urology and Nephrology 14: 139–141, 1980

    PubMed  Google Scholar 

  • Martin MR, Schiff AA. Fluphenazine/nortriptyline in the irritable bladder syndrome: a double-blind placebo-controlled study. British Journal of Urology 56: 178–179, 1984

    PubMed  CAS  Google Scholar 

  • Massey JA, Abrams P. Dose titration in clinical trials: an example using emepronium carrageenate in detrusor instability. British Journal of Urology 58: 125–128, 1986

    PubMed  CAS  Google Scholar 

  • Mattiasson A, Ekström B, Andersson K-E. Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity. Neurourology and Urodynamics 6: 253–254, 1987

    Google Scholar 

  • McGuire EJ. Urethral sphincter mechanisms. Urologic Clinics of North America 6: 39–49, 1979

    PubMed  CAS  Google Scholar 

  • McGuire EJ, Wagner FM, Weiss RM. Treatment of autonomic dysreflexia with phenoxybenzamine. Journal of Urology 115: 53–55, 1976

    PubMed  CAS  Google Scholar 

  • Moisey CU, Stephenson TP, Brendler CB. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. British Journal of Urology 52: 472–475, 1980

    PubMed  CAS  Google Scholar 

  • Naglo AS, Nergårdh A, Boreus LO. Influence of atropine and isoprenaline on detrusor hyperactivity in children with neurogenic bladder. Scandinavian Journal of Urology and Nephrology 15: 97–102, 1981

    PubMed  CAS  Google Scholar 

  • Nergårdh A, Boreus LO, Naglo AS. Characterization of the adrenergic beta-receptor in the urinary bladder of man and cat. Acta Pharmacologica et Toxicologica 40: 14–21, 1977

    PubMed  Google Scholar 

  • Nilvebrant L, Andersson K-E, Mattiasson A. Characterization of the muscarinic cholinoceptors in the human detrusor. Journal of Urology 134: 418–423, 1985

    PubMed  CAS  Google Scholar 

  • Nissenkorn I, Katz A, Rubinstein K, Cohen S. Selective effect of nortriptyline on smooth muscle as an anticholinergic drug: a pharmacological and clinical study. European Journal of Urology 12: 109–112, 1986

    CAS  Google Scholar 

  • Noack CH. Enuresis nocturna: a long-term study of 44 children treated with imipramine hydrochloride (Tofranil) and other drugs. Medical Journal of Australia 1: 191–194, 1964

    PubMed  CAS  Google Scholar 

  • Nordling J, Meyhoff HH, Christensen NJ. Effects of clonidine (Catapresan) on urethral pressure. Investigative Urology 4: 289–291, 1979

    Google Scholar 

  • Norlén L, Sundin T, Waagstein F. Beta-adrenoceptor stimulation of the human urinary bladder in vivo. Acta Pharmacologica et Toxicologica 43(Suppl. II): 26–30, 1978

    PubMed  Google Scholar 

  • Olubadewo JO. The effect of imipramine on rat detrusor muscle contractility. Archives Internationales de Pharmacodynamie et de Thérapie 245: 84–94, 1980

    PubMed  CAS  Google Scholar 

  • Østergaard JR, Østergaard K, Andersson K-E, Sommer L. Calcium antagonistic effects of terodiline in rabbit aorta and human uterus. Acta Pharmacologica et Toxicologica 46(Suppl. I): 12–20, 1980

    PubMed  Google Scholar 

  • Palmer, JH, Worth PHL, Exton-Smith AN. Flunarizine: a once daily therapy for urinary incontinence. Lancet 2: 279–281, 1981

    PubMed  CAS  Google Scholar 

  • Paulson DF. Oxybutynin chloride in control of post-transurethral vesical pain and spasm. Urology 11: 237–238, 1978

    PubMed  CAS  Google Scholar 

  • Perera GLS, Ritch AES, Hall MRP. The lack of effect of intramuscular emepronium bromide for urinary incontinence. British Journal of Urology 54: 259–260, 1982

    PubMed  CAS  Google Scholar 

  • Perlberg S, Caine M. Adrenergic response of bladder muscle in prostatic obstruction. Urology 20: 524–537, 1982

    PubMed  CAS  Google Scholar 

  • Peters D, the Multicenter Group. Terodiline in the treatment of urinary frequency and motor urge incontinence: a controlled multicenter trial. Scandinavian Journal of Urology and Nephrology (Suppl. 87): 21–33, 1984

    Google Scholar 

  • Philp NH, Thomas DG, Clarke SJ. Drug effects on the voiding cystouretrogram — a comparison of oral bethanechol and carbachol. British Journal of Urology 52: 484–487, 1980

    PubMed  CAS  Google Scholar 

  • Pietra C, Cazzulani P, Cova A, Tajana A, Ceserani K. Effects of flavoxate hydrochloride on voiding contractions and cystometric recordings of rat urinary bladder after oral administration. Proceedings of the Third Joint Meeting ICS-UDS, pp. 10–11, Boston, 1986

  • Post EM, Richman RA, Blackett PR, Duncan KP, Miller K. Desmopressin response of enuretic children. American Journal of Diseases in Children 137: 962–963, 1983

    CAS  Google Scholar 

  • Raezer DM, Benson GS, Wein AJ, Duckett Jr JW. The functional approach to the management of the pediatric neuropathic bladder a clinical study. Journal of Urology 177: 649–654, 1977

    Google Scholar 

  • Ramsay JWA, Scott GJ, Whitfield HN. A double-blind controlled trial of a new α-1 blocking drug in the treatment of bladder outflow obstruction. British Journal of Urology 57: 657–659, 1985

    PubMed  CAS  Google Scholar 

  • Ramsden PD, Hindmarsh JR, Price DA, Yeates WK, Bowditch JDP. DDAVP for adult enuresis — a preliminary report. British Journal of Urology 54: 256–258, 1982

    PubMed  CAS  Google Scholar 

  • Raz S, Zeigler M, Caine M. The role of female hormones in stress incontinence. Proceedings of the 16th Congress of the Société International d’Urologie, Vol. 2, pp. 397–402, Amsterdam, Docri, Paris, 1973

  • Reuther K, Aagaard J. α-Adrenergic blockade in the diagnosis of detrusor instability secondary to infravesical obstruction. Urologia Internationalis 39: 312–313, 1984

    PubMed  CAS  Google Scholar 

  • Ritch A, George C, Hall MRP. A second look at emepronium bromide in urinary incontinence. Lancet 1: 504–506, 1977

    PubMed  CAS  Google Scholar 

  • Riva D, Casolati E. Oxybutynin chloride in the treatment of female idiopathic bladder instability. Clinical and Experimental Obstetrics and Gynecology 11: 37–42, 1984

    CAS  Google Scholar 

  • Robinson JM, Brocklehurst JC. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women. British Journal of Urology 55: 371–376, 1983

    PubMed  CAS  Google Scholar 

  • Rohner TJ, Hannigan JD, Sanford EJ. Altered in vitro adrenergic response of dog detrusor muscle after chronic bladder outlet obstruction. Urology 11: 357–361, 1978

    PubMed  CAS  Google Scholar 

  • Roussan MS, Abramson AS, Levine SA, Feibel A. Bladder training: its role in evaluating the effect of an antispasticity drug on voiding in patients with neurogenic bladder. Archives of Physical Medicine and Rehabilitation 56: 463–468, 1975

    PubMed  CAS  Google Scholar 

  • Rud T. The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstetrica et Gynecologica Scandinavica 59: 265–270, 1980

    CAS  Google Scholar 

  • Rud T, Andersson K-E, Ulmsten U. Effects of nifedipine in women with unstable bladders. Urologia Internationalis 34: 421–429, 1979

    PubMed  CAS  Google Scholar 

  • Salmon UJ, Walter RJ, Geist SH. The use of estrogen in the treatment of dysuria and incontinence in postmenopausal women. American Journal of Obstetrics and Gynecology 42: 845–851, 1941

    Google Scholar 

  • Schreiter F, Fricks P, Stockamp K. Estrogenic sensitivity of alpha-adrenoceptors in the urethral musculature. Urologia Internationalis 31: 13–19, 1976

    PubMed  CAS  Google Scholar 

  • Sibley GNA. A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. Journal of Physiology 354: 431–443, 1984

    PubMed  CAS  Google Scholar 

  • Sjögren C, Andersson K-E, Husted S, Mattiasson A, Mailer Madsen B. Atropine resistance of transmurally stimulated isolated human bladder muscle. Journal of Urology 128: 1368–1371, 1982

    PubMed  Google Scholar 

  • Sole G, Arkell DG. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence. Scandinavian Journal of Urology and Nephrology (Suppl. 87): 55–57, 1984

    Google Scholar 

  • Stanton SL. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence. Journal of Urology 110: 529–532, 1973

    PubMed  CAS  Google Scholar 

  • Stewart BH, Banowski LHW, Montague DK. Stress incontinence: conservative therapy with sympathomimetic drugs. Journal of Urology 115: 558–559, 1976

    PubMed  CAS  Google Scholar 

  • Sundwall J, Vessman J, Strindberg B. Fate of emepronium bromide in man in relation to its pharmacological effects. European Journal of Clinical Pharmacology 6: 191–195, 1973

    PubMed  CAS  Google Scholar 

  • Syversen JHN, Møllestad E, Semb LS. Emepronium bromide (Cetiprin) as a postoperative spasmolytic agent in transvesical prostatectomy. Scandinavian Journal of Urology and Nephrology 10: 201–203, 1976

    PubMed  CAS  Google Scholar 

  • Tammela T, Kontturi M, Käär K, Lukkarinen O. Intravesical prostaglandin E2 for promoting bladder emptying after surgery for female stress incontinence. British Journal of Urology 60: 43–46, 1987

    PubMed  CAS  Google Scholar 

  • Tapp A, Fall M, Norgaard J, Massey A, Choa R, et al. A dose-titrated, multi-centre study of terodiline in the treatment of detrusor instability. Neurourology and Urodynamics 6: 254–255, 1987

    Google Scholar 

  • Taylor MC, Bates CP. A double-blind crossover trial of baclofen — a new treatment for the unstable bladder syndrome. British Journal of Urology 51: 504–505, 1979

    PubMed  CAS  Google Scholar 

  • Taylor MC, Bates CP. DDAVP in the management of nocturnal frequency and enuresis due to bladder instability. Proceedings of the International Continence Society 11th Annual Meeting, pp. 144–145, Lund, 1981

  • Taylor P. Cholinergic agonists. In Gilman et al. (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 100–109, McMillan Publishing Company, New York, 1985

    Google Scholar 

  • Tulloch AGS, Creed KE. A comparison between propantheline and imipramine on bladder and salivary gland fonction. British Journal of Urology 51: 359–362, 1979

    PubMed  CAS  Google Scholar 

  • Ulmsten U, Andersson K-E. The effects of emeprone on intravesical and intraurethral pressures in women with urgency incontinence. Scandinavian Journal of Urology and Nephrology 11: 103–109, 1977

    PubMed  CAS  Google Scholar 

  • Ulmsten U, Ekman G, Andersson K-E. The effect of terodiline treatment in women with motor urge incontinence. American Journal of Obstetrics and Gynecology 153: 619–622, 1985

    PubMed  CAS  Google Scholar 

  • Vaidyanathan S, Rao MS, Mapa KK, Bapna BC, Chary KSN, et al. Study of intravesical instillation of 15(S)-15 methyl prostaglandin F2 alpha in patients with neurogenic bladder dysfunction. Journal of Urology 126: 81–85, 1981

    PubMed  CAS  Google Scholar 

  • Vose CW, Ford G-C, Grigson SJW, Haskins NJ, Prout M, et al. Pharmacokinetics of propantheline bromide in normal man. British Journal of Pharmacology 7: 89–93, 1979

    CAS  Google Scholar 

  • Wagner G, Husslein P, Enzelsberger H. Is prostaglandin E2 really of therapeutic value for postoperative urinary retention: results of a prospectively randomized double-blind study. American Journal of Obstetrics and Gynecology 151: 375–379, 1985

    PubMed  CAS  Google Scholar 

  • Walter S, Hansen J, Hansen L, Maegaard E, Meyhoff HH, et al. Urinary incontinence in old age. British Journal of Urology 54: 249–251, 1982

    PubMed  CAS  Google Scholar 

  • Wein AJ. Lower urinary tract function and pharmacologic management of lower urinary tract dysfunction. Urologic Clinics of North America 14: 273–296, 1987

    PubMed  CAS  Google Scholar 

  • Wein AJ, Hanno PM, Dixon DO, Raezer DM, Benson GS. The effect of oral bethanechol chloride on the cysto-uretrogram of the normal male adult. Journal of Urology 120: 330–331, 1978

    PubMed  CAS  Google Scholar 

  • Wein AJ, Levin RM, Barrett DM. Voiding function: relevant anatomy, physiology, pharmacology. In Gillenwater et al. (Eds) Textbook of urology, Year Book Medical Publishers, Chicago, 1987

    Google Scholar 

  • Zorzitto ML, Jewett MAS, Fernie GR, Holliday PJ, Bartlett S. Effectiveness of propantheline bromide in the treatment of geriatric patients with detrusor instability. Neurourology and Urodynamics 5: 133–140, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, University Hospital of Lund, S-221 85, Lund, Sweden

    Karl-Erik Andersson

Authors
  1. Karl-Erik Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersson, KE. Current Concepts in the Treatment of Disorders of Micturition. Drugs 35, 477–494 (1988). https://doi.org/10.2165/00003495-198835040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198835040-00006

Keywords

Search

Navigation